MethodSense Corporate Backgrounder
-
MethodSense Corporate Backgrounder
The Corporate Backgrounder provides an overview of MethodSense, who we are, what we do, and how we help medical technology companies achieve regulatory and commercial success. It highlights our expertise in regulatory strategy, quality systems, and capital alignment, along with the role of the LuminLogic platform in supporting successful product development and market authorization.
-
MethodSense Launches Capital & Investment Strategy Advisory for the MedTech Sector
New practice aligns regulatory intelligence with fundable growth and confident capital deployment… MORRISVILLE, NC – March 10, 2026, MethodSense, a regulatory and quality advisory firm serving the medical device industry, today announced the launch of its Capital & Investment Strategy advisory practice, designed to align regulatory intelligence with capital decisions across the MedTech lifecycle. As…
-
MethodSense Receives Global Reach Award for Trade Excellence from NC Governor Stein and EDPNC
Honored for advancing North Carolina’s global life sciences presence through regulatory intelligence and compliance technology… MORRISVILLE, NC – March 05, 2026, MethodSense, a North Carolina–based regulatory and quality advisory firm serving the global life sciences industry, has been recognized for Export Trade Excellence by Josh Stein, in partnership with the Economic Development Partnership of North…
-
The FDA Just Went AI. Are You Ready?
Elsa Signals the Start of the FDA’s AI Era. Here’s What It Means for YouBy Rita King, CEO, MethodSense The FDA just dropped a game-changer: Elsa, its new generative AI tool. And it’s already transforming how medical device companies are evaluated and regulated. Elsa is actively supporting FDA reviews. At MethodSense, we have already seen…